Fulgent Genetics Inc (FLGT)
16.95
-0.33
(-1.91%)
USD |
NASDAQ |
Nov 21, 16:00
17.99
+1.04
(+6.14%)
Pre-Market: 09:14
Fulgent Genetics Shareholders Equity (Quarterly): 1.138B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.138B |
| June 30, 2024 | 1.133B |
| March 31, 2024 | 1.130B |
| December 31, 2023 | 1.136B |
| September 30, 2023 | 1.259B |
| June 30, 2023 | 1.260B |
| March 31, 2023 | 1.264B |
| December 31, 2022 | 1.267B |
| September 30, 2022 | 1.277B |
| June 30, 2022 | 1.305B |
| March 31, 2022 | 1.306B |
| December 31, 2021 | 1.159B |
| September 30, 2021 | 1.037B |
| June 30, 2021 | 912.73M |
| March 31, 2021 | 801.57M |
| December 31, 2020 | 569.39M |
| September 30, 2020 | 186.96M |
| June 30, 2020 | 87.04M |
| Date | Value |
|---|---|
| March 31, 2020 | 81.37M |
| December 31, 2019 | 82.78M |
| September 30, 2019 | 54.53M |
| June 30, 2019 | 51.14M |
| March 31, 2019 | 49.96M |
| December 31, 2018 | 51.15M |
| September 30, 2018 | 52.58M |
| June 30, 2018 | 52.56M |
| March 31, 2018 | 53.02M |
| December 31, 2017 | 54.18M |
| September 30, 2017 | 55.27M |
| June 30, 2017 | 55.73M |
| March 31, 2017 | 55.30M |
| December 31, 2016 | 54.48M |
| September 30, 2016 | 17.24M |
| June 30, 2016 | 21.70M |
| December 31, 2015 | 5.146M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
81.37M
Minimum
Mar 2020
1.306B
Maximum
Mar 2022
919.60M
Average
1.134B
Median
Shareholders Equity (Quarterly) Benchmarks
| Delcath Systems Inc | 8.571M |
| Star Equity Holdings Inc | 58.37M |
| Exact Sciences Corp | 3.211B |
| CytoSorbents Corp | 13.00M |
| Progyny Inc | 434.88M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.234B |
| Total Liabilities (Quarterly) | 98.86M |
| Debt to Equity Ratio | 0.0026 |
| Current Ratio | 4.413 |
| Net Debt Paydown Yield | 0.05% |